- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05585242
Acceptance and Commitment Therapy (ACT) Adapted for Women With Infertility-related Distress
April 3, 2025 updated by: Jennifer Gordon, University of Regina
Randomized Control Trial of Acceptance and Commitment Therapy Adapted for Women With Infertility-related Distress
This RCT will test the effect of a 7-week self-help ACT-based program in improving fertility-related quality of life and psychological flexibility, in women with infertility.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Ninety women with infertility living in Canada and the United States will be recruited.
They will be emailed seven weekly 15-minute videos, each providing instructions on a new Acceptance and Commitment Therapy-based technique that addresses the impact of infertility on psychological inflexibility and distress.
Fertility-related quality of life and psychological flexibility will be measured before and after the program.
Outcomes will also be measured at one-month follow-up.
Feedback about how to improve the program will also be collected.
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Saskatchewan
-
Regina, Saskatchewan, Canada, S4S 0A2
- University of Regina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 42 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Has been trying to get pregnant for 12+ months and has failed OR is currently undergoing fertility treatments
- Lives in Canada or the United States
- Reports a high level of distress related to infertility, as indicated by a FertiQoL score below 71
Exclusion Criteria:
- Is currently experiencing active suicidal ideation, as indicated by a score of 7 or above on the Suicide Behaviours Questionnaire - Revised (SBQ-R)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
The program consists of brief weekly videos, each addressing a particular Acceptance and Commitment Therapy technique to be implemented that week.
Participants receive the videos by email from the researcher and watch them on their own.
Each video also assigns a "homework" exercise for the participant to complete that week and includes a summary of the module.
|
Seven 15-minutes videos of Acceptance and commitment therapy adapted for women with infertility with assigned homework and summaries of the videos.
|
|
No Intervention: Waistlist
Participants in the waitlist control condition will complete the same measures as the intervention group.
After they have completed their one-month follow-up measures they will be given the opportunity to receive the intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fertility Quality of Life tool (Fertiqol)
Time Frame: Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
|
Pre-to-post change in quality of life related to a diagnosis of infertility.
Scores range from 0-100, with higher scores indicating better quality of life.
|
Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
|
|
Psychological flexibility (MPFI)
Time Frame: Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
|
Pre-to-post change in psychological flexibility.
Higher scores on the flexibility sub scale indicating better psychological flexibility.
|
Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
|
Pre-to-post change in anxious symptoms; Scores range from 0-21, with higher scoresindicating more severe anxiety
|
Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
|
|
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
|
Pre-to-post change in depressive symptoms; Scores range from 0-27, with higherscores indicating more severe depressive symptoms
|
Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 13, 2023
Primary Completion (Actual)
November 1, 2023
Study Completion (Actual)
December 1, 2023
Study Registration Dates
First Submitted
October 14, 2022
First Submitted That Met QC Criteria
October 14, 2022
First Posted (Actual)
October 18, 2022
Study Record Updates
Last Update Posted (Actual)
April 8, 2025
Last Update Submitted That Met QC Criteria
April 3, 2025
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REB 2022-026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility, Female
-
Yuzuncu Yil UniversityCompletedUnexplained Infertility | Female Infertility | Anovulatory InfertilityTurkey (Türkiye)
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Newlife Fertility CentreRecruitingInfertility | Infertility,Female | Infertility Unexplained | Infertility of Uterine Origin | Infertility; Female, NonimplantationCanada
-
BEYOND GENOMiX SA, AG, LtdPraxis für Akupunktur und Chinesische Arzneimittel; Fertisuisse Ltd, SA, AGRecruitingInfertility Unexplained | Infertility (IVF Patients) | Idiopathic Infertility | Infertility Female | Infertility Assisted Reproductive TechnologySwitzerland
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Cairo UniversityCompleted
-
Navy General Hospital, BeijingUnknownFemale Infertility Due to Nonimplantation of OvumChina
Clinical Trials on Infertility ACTion Program
-
University of ReginaRecruitingInfertility, FemaleCanada
-
University of ReginaCanadian Institutes of Health Research (CIHR); University of Calgary; Saskatchewan...Not yet recruitingInfertility | Distress, Emotional | Mental Health IssueCanada
-
University of CoimbraPortuguese Fertility AssociationCompletedInfertility
-
Boston Medical CenterActive, not recruiting
-
Port Said UniversityMansoura University; Prince Sattam Bin Abdulaziz UniversityRecruitingFertility IssuesEgypt
-
Ain Shams UniversityUnknownUnexplained InfertilityEgypt
-
Università Vita-Salute San RaffaeleRecruitingFemale InfertilityItaly
-
The University of Hong KongNot yet recruiting
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Hospital de Clinicas de Porto AlegreTelessaúde RSNot yet recruitingInfertility | Telemedicine | Health Education | TelehealthBrazil